Orion Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Orion Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75	Closed	-$30.4K	–	572
2025 Q2	$30.4K	Sell	75 -79	-51%	-$33K	0.01%	291
2025 Q1	$76.6K	Sell	154 -260	-63%	-$141K	0.03%	201
2024 Q4	$215K	Hold	414	–	–	0.09%	120
2024 Q3	$256K	Sell	414 -1	-0.2%	-$592	0.12%	104
2024 Q2	$229K	Hold	415	–	–	0.12%	107
2024 Q1	$241K	Sell	415 -4	-1%	-$2.25K	0.13%	105
2023 Q4	$222K	Sell	419 -35	-8%	-$16.9K	0.13%	115
2023 Q3	$230K	Hold	454	–	–	0.15%	106
2023 Q2	$237K	Hold	454	–	–	0.16%	110
2023 Q1	$262K	Hold	454	–	–	0.18%	96
2022 Q4	$250K	Hold	454	–	–	0.18%	94
2022 Q3	$230K	Hold	454	–	–	0.19%	93
2022 Q2	$247K	Hold	454	–	–	0.19%	90
2022 Q1	$268K	Buy	454 +38	+9%	+$21.8K	0.16%	98
2021 Q4	$278K	Hold	416	–	–	0.16%	97
2021 Q3	$238K	Buy	416 +21	+5%	+$11.5K	0.14%	101
2021 Q2	$199K	Buy	395 +15	+4%	+$7.08K	0.12%	110
2021 Q1	$173K	Buy	+380	New	+$181K	0.12%	111

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Orion Capital Management's TMO Position: Q3 2025 in Review

Orion Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 75 shares — an estimated $30.4K sold.

Orion Capital Management first reported a position in TMO in Q1 2021 and held it in 18 quarters. The position peaked at $278K in Q4 2021. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Orion Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Orion Capital Management sold 75 Thermo Fisher Scientific shares in Q3 2025, an estimated $30.4K.
Orion Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 18 quarters.
Orion Capital Management's Thermo Fisher Scientific position peaked at $278K in Q4 2021.
2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Orion Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.